Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,37 USD | -1,33% | +2,27% | -70,87% |
Vakgebied
Aantal werknemers: 4
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John Climaco
CEO | Chief Executive Officer | 55 | 01-09-17 |
Director of Finance/CFO | 45 | 13-11-19 | |
Sandra Silberman
CTO | Chief Tech/Sci/R&D Officer | 69 | 01-12-17 |
Donald Picker
CTO | Chief Tech/Sci/R&D Officer | 78 | 01-01-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Donald Picker
CTO | Chief Tech/Sci/R&D Officer | 78 | 01-01-18 |
John Climaco
CEO | Chief Executive Officer | 55 | 01-09-17 |
Faith Charles
CHM | Chairman | 62 | 03-01-23 |
Jeffry Keyes
BRD | Director/Board Member | 51 | 25-06-18 |
Bettina Cockroft
BRD | Director/Board Member | 57 | 08-05-23 |
Jerzy Gumulka
BRD | Director/Board Member | 75 | 08-11-17 |
Carl Evans
BRD | Director/Board Member | 77 | 09-07-18 |
Amy Mahery
BRD | Director/Board Member | - | 18/01 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 8 430 265 | 5 078 906 ( 60,25 %) | 0 | 60,25 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-70,87% | 2,3 mln. | |
+9,16% | 45,97 mld. | |
+53,58% | 43,93 mld. | |
+11,20% | 42,34 mld. | |
-8,59% | 28,27 mld. | |
+16,40% | 27,18 mld. | |
-19,34% | 19,44 mld. | |
+13,95% | 13,83 mld. | |
+31,56% | 12,4 mld. | |
+10,63% | 11,45 mld. |
- Beurs
- Aandelen
- Aandeel CNS Pharmaceuticals, Inc. - Nasdaq
- Onderneming CNS Pharmaceuticals, Inc.